Mycobacterial virulence. Virulent strains of mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhlbiting functions of macrophages in the presence and absence of specific immunity

Journal of Experimental Medicine

Volumn 177, Issue 6, 1993, Pages 1723-1733

  North, Robert J ^a   Izzo, Angelo A ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE;

ANIMAL CELL; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNOCOMPETENCE; MACROPHAGE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; COMPARATIVE STUDY; HYDROCORTISONE; KIDNEY; LIVER; MACROPHAGES; MICE; MICE, SCID; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; SUPPORT, NON-U.S. GOV'T; TUBERCULOSIS; VIRULENCE;

EID: 0027194956     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.6.1723     Document Type: Article

References (16)

1. Pierce, C.H., R.J. Dubos, and W.B. Schaefer. 1953. Multiplication and survival of tubercle bacilli in the organs of mice. J. Exp Mel 97:189.
2. + cells in the immunogenic control of infection with Mycobacteria bovis strain Bacillus Calmette-Guerin in mice. J. Immunol. 139:2032.
3. + T cells. J. Exp Med. 176:581.
4. Orme, I.M. 1988. Evidence for biphasic memory T-cell-response to high dose BCG vaccination in mice. Tubercle. 69:125.
5. Leveton, C., S. Barnass, B. Champion, S. Lucas, B. DeSousa, M. Nicol, D. Banerjee, and G. Rook. 1989. T cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect. Immun. 57:390.
6. Larson, C.L., and W.C. Wicht. 1962. Studies of resistance to experimental tuberculosis in mice vaccinated with living attenuated tubercle bacilli and challenged with virulent organisms. Am. Rev. Respir. Dis. 85:833.
7. Lefford, M.J. 1977. Induction and expression of immunity after BCG immunization. Infect. Immun. 18:646.
8. Bloom, B.R., and W.R. Jacobs. 1989. New strategies for leprosy and tuberculosis and for development of Bacillus Calmette-Guerin into a multivaccine vehicle. Ann. NY. Acad. Sci. 569:155.
9. Kaufmann, S.H.E. 1990. Vaccines against tuberculosis: the impact of modem biotechnology. Scand.J. Infect. Dis. Suppl. 76:54.
10. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp Med. 172:937.
11. Lechtman, M.D., J.W. Bartholomew, A. Phillips, and M. Russo. 1965. Rapid method for staining bacterial spores at room temperature. J. Bacteriol. 89:848.
12. Masur, H., H.W. Murray, and T.C. Jones. 1982. Effect of hydrocortisone on macrophage response to lymphokine. Infect. Immun. 35:709.
13. Schaffner, A. 1985. Therapeutic concentrations for glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J. Clin. Invest. 76:1755.
14. Centers for Disease Control. 1991. Tuberculosis and human immunodeficiency virus infection. Recommendations of the advisory committee for the elimination of tuberculosis (ACET). MMWR (Morb Mortal. Wkly. Rep) 38:236.
15. Centers for Disease Control. 1991. Tuberculosis outbreak among persons in a residential facility for HIV-infected persons—San Francisco. MMWR (Morb Mortal. Wkly. Rep) 40:649.
16. Centers for Disease Control. 1991. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988-1991. MMWR (Morb Mortal. Wkly. Rep) 40:585.